Sleep impairment

Sleep impairment has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Nov 7, 2026: “Sleep problems’ link to cardiovascular deaths varied by risk”.

Exposure

1 paper studies it1 findingUpdated

1 new paper in 30 daysSee all 1 papers on sleep impairment

At a glance

The findings reach people, from one lab or study. 1 lab.

“indicating synergistic excess risk among those with concurrent sleep impairment and advanced CKM burden.”
Sleep Impairment Burden and Cardiovascular Mortality Across CKM Stages: Evidence of Synergistic Interaction from NHANES 2005-2018AHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.16353
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab
  • Humans1

What is sleep impairment linked with?

1

Studies link sleep impairment with 1 measure, most often cardiovascular mortality (1 study).

Cardiovascular mortality

upin humans1

1 study
  1. Sleep impairment is associated with cardiovascular mortality in humans (Synergistic interaction with CKM stage; RERI estimate for SBI2 at CKM Stage 3) (CKM Stage 3, SBI2: RERI +1.388, 95% CI 0.523–1.697; global interaction p=5.9×10−12).

    “indicating synergistic excess risk among those with concurrent sleep impairment and advanced CKM burden.”

    HumansSynergistic interaction with CKM stage; RERI estimate for SBI2 at CKM Stage 3

    Sleep problems’ link to cardiovascular deaths varied by risk

    AHA Scientific Sessions 2026 abstract

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
AHA Scientific Sessions 2026 Abstract

Sleep problems’ link to cardiovascular deaths varied by risk

Sleep scores of one and two had adjusted hazard ratios of 0.907 and 1.117 versus zero, relative death-rate measures whose uncertainty ranges included no difference.Sleep scores of one and two had adjusted hazard ratios of 0.907 and 1.117 versus zero, relative death-rate measures whose uncertainty ranges included no difference.

Cohort · 33,661 peopleCardiovascular disease